机译:六个月生活方式干预对肥胖青少年脂联素,抵抗素和可溶性肿瘤坏死因子-α受体的影响
Laboratory of Pharmacology and Toxicology, Hospital Infantil de Mexico Federico Gomez (HIMFG), Mexico City 06720, Mexico;
Department of Allergy, Hospital Infantil de Mexico Federico Gomez, Marquez No. 162, Mexico City 06720, Mexico;
Laboratory of Pharmacology and Toxicology, Hospital Infantil de Mexico Federico Gomez (HIMFG), Mexico City 06720, Mexico;
Center Laboratories, HIMFG, Mexico City 06720, Mexico;
Department of Allergy, HIMFG, Mexico City 06720, Mexico;
Superior School of Medicine, National Polytechnic Institute, Mexico City 11340, Mexico;
Department of Pharmacobiology, Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City 14330, Mexico;
Department of Pharmacobiology, Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City 14330, Mexico;
Department of Pharmacobiology, Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City 14330, Mexico;
Adiponectin; Resistin; Tumor necrosis factor-α receptor; Life-style intervention; Obese adolescents;
机译:六个月生活方式干预对肥胖青少年脂联素,抵抗素和可溶性肿瘤坏死因子-α受体的影响
机译:长期跨学科生活方式治疗减少的内脏脂肪与肥胖青少年的白介素-6和肿瘤坏死因子-α呈正相关,与脂联素水平呈负相关。
机译:瘦患者的可溶性肿瘤坏死因子-α受体血浆水平与总胆固醇和低密度脂蛋白胆固醇有关,但与肥胖受试者无关
机译:通过可溶性糖皮质激素诱导的肿瘤坏死因子受体(Sgitr)分泌MMP-9是由鼠巨噬细胞的磷脂酶D(PLD)介导的介导
机译:单纯生活方式或药物疗法对肥胖青少年体重控制和代谢综合征标志物的影响。
机译:瘦患者的可溶性肿瘤坏死因子-α受体血浆水平与总胆固醇和低密度脂蛋白胆固醇有关但与肥胖受试者无关
机译:肥胖男性或不患有脂肪肝的脂联素和可溶性肿瘤坏死因子-α受体2(SNFαR2)的水平